Aspirin and Plavix

PreclinicalSmall molecule

AAssaf-Harofeh Medical Center

Aspirin and Plavix is one of 6 small molecule programs targeting Absorption. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

AbsorptionCompleted

AbsorptionPreclinical

Completed

Competition

Competitive Landscape

6 competitors in Absorption

#DrugCompanyPhaseTrials

Hezkue

AAspargo Labs, Inc

Phase 2

1 2

Cytovene

EExela Pharma Sciences, LLC.

Preclinical

1 3

Rifampicin

Boehringer Ingelheim

Preclinical

1 4

Procysbi

HHorizon Therapeutics Ireland DAC

Preclinical

1 5

Aspirin and Plavix

AAssaf-Harofeh Medical Center

Preclinical

1 6

Oshadi D

OOshadi Drug Administration

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Clopidogrel1 trial

Thromboelastography As An Assessment Tool for Possible Clopidogrel and Aspirin Resistance

Unknown status·—·Phase 3·NCT00697021·50 enrolled

Absorption1 trial

Pharmacological Study That Measures Omeprazole Effect on Aspirins Absorption in Healthy Volunteers

Completed·—·N/A·NCT01061034·9 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Aspirin and Plavix. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Aspirin and Plavix compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Aspirin and Plavix. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Assaf-Harofeh Medical Center company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: AAssaf-Harofeh Medical Center

Aspirin and Plavix

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Clopidogrel1 trial

Absorption1 trial

References

Drug Info

Quick Facts

Related News